Longitudinal Retinal Changes in MOGAD

Oertel, Frederike Cosima; Sotirchos, Elias S.; Zimmermann, Hanna G.; Motamedi, Seyedamirhosein; Specovius, Svenja; Asseyer, Eva Susanna; Chien, Claudia; Cook, Lawrence; Vasileiou, Eleni; Filippatou, Angeliki; Calabresi, Peter A.; Saidha, Shiv; Pandit, Lekha; D'Cunha, Anitha; Outteryck, Olivier; Zephir, Helene; Pittock, Sean; Flanagan, Eoin P.; Bhatti, M. Tariq; Rommer, Paulus S.; Bsteh, Gabriel; Zrzavy, Tobias; Kümpfel, Tania; Aktas, Orhan; Ringelstein, Marius; Albrecht, Philipp; Ayzenberg, Ilya; Pakeerathan, Thivya; Knier, Benjamin; Aly, Lilian; Asgari, Nasrin; Soelberg, Kerstin; Marignier, Romain; Tilikete, Caroline Froment; Calvo, Alvaro Cobo; Villoslada, Pablo; Sanchez-Dalmau, Bernardo; Martinez-Lapiscina, Elena H.; Llufriu, Sara; Green, Ari J.; Yeaman, Michael R.; Smith, Terry J.; Brandt, Alexander U.; Chen, John; Paul, Friedemann und Havla, Joachim (2022): Longitudinal Retinal Changes in MOGAD. In: Annals of Neurology, Bd. 92, Nr. 3: S. 476-485

Abstract

Objective Patients with myelin oligodendrocyte glycoprotein antibody (MOG-IgG)-associated disease (MOGAD) suffer from severe optic neuritis (ON) leading to retinal neuro-axonal loss, which can be quantified by optical coherence tomography (OCT). We assessed whether ON-independent retinal atrophy can be detected in MOGAD. Methods Eighty patients with MOGAD and 139 healthy controls (HCs) were included. OCT data was acquired with (1) Spectralis spectral domain OCT (MOGAD: N = 66 and HCs: N = 103) and (2) Cirrus high-definition OCT (MOGAD: N = 14 and HCs: N = 36). Macular combined ganglion cell and inner plexiform layer (GCIPL) and peripapillary retinal nerve fiber layer (pRNFL) were quantified. Results At baseline, GCIPL and pRNFL were lower in MOGAD eyes with a history of ON (MOGAD-ON) compared with MOGAD eyes without a history of ON (MOGAD-NON) and HCs (p < 0.001). MOGAD-NON eyes had lower GCIPL volume compared to HCs (p < 0.001) in the Spectralis, but not in the Cirrus cohort. Longitudinally (follow-up up to 3 years), MOGAD-ON with ON within the last 6-12 months before baseline exhibited greater pRNFL thinning than MOGAD-ON with an ON greater than 12 months ago (p < 0.001). The overall MOGAD cohort did not exhibit faster GCIPL thinning compared with the HC cohort. Interpretation Our study suggests the absence of attack-independent retinal damage in patients with MOGAD. Yet, ongoing neuroaxonal damage or edema resolution seems to occur for up to 12 months after ON, which is longer than what has been reported with other ON forms. These findings support that the pathomechanisms underlying optic nerve involvement and the evolution of OCT retinal changes after ON is distinct in patients with MOGAD. ANN NEUROL 2022

• Dokumententyp: Zeitschriftenartikel
• Fakultät: Medizin
• Themengebiete: 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit
• ISSN: 0364-5134
• Sprache: Englisch